Lessee, Operating Lease, Liability, to be Paid, Year Two of MADRIGAL PHARMACEUTICALS, INC. from 31 Dec 2021 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
- Summary
-
MADRIGAL PHARMACEUTICALS, INC. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
- MADRIGAL PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Dec 2025 was $2,065,000, a 93% increase year-over-year.
- Source SEC data
- View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)
MADRIGAL PHARMACEUTICALS, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $2,065,000 | +$993,000 | +93% | 31 Dec 2025 | 10-K | 19 Feb 2026 | 2025 | FY |
| Q4 2024 | $1,072,000 | +$594,000 | +124% | 31 Dec 2024 | 10-K | 26 Feb 2025 | 2024 | FY |
| Q4 2023 | $478,000 | 31 Dec 2023 | 10-K | 28 Feb 2024 | 2023 | FY | ||
| Q4 2021 | $400,000 | 31 Dec 2021 | 10-K | 24 Feb 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.